{
    "nctId": "NCT00569543",
    "briefTitle": "Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer",
    "officialTitle": "Effects of Therapeutic Agents on Estrogens in the Breast",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 27,
    "primaryOutcomeMeasure": "Comparison of estrogen compounds in urine",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Newly diagnosed ductal carcinoma in situ or invasive breast cancer\n* Scheduled to receive tamoxifen citrate or an aromatase inhibitor\n* Estrogen receptor or progesterone receptor positive\n* ECOG performance status 0, 1, or 2\n\nExclusion Criteria:\n\n* Not pregnant or nursing\n* No prior antiestrogen drug such as tamoxifen citrate or raloxifene\n* No concurrent estrogens",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}